msn.com: Roughly 1 in 8 Florida prisoners is in solitary confinement
UC research collaboration looks at the detriments and biases of extended solitary management
A study of Florida’s Department of Corrections data, co-authored by UC criminal justice researcher Joshua Cochran, PhD, recently found that people in certain demographic groups are more likely to be placed in long-term solitary confinement than other prisoners in Florida. The study identified those demographic groups as Black people, men, young people and those with mental health issues.
This study sought to shed light on extended solitary management (ESM) that typically entails a minimum 6-month stay and up to 23-hour per day isolation in a separate facility and is used for managing individuals deemed to be otherwise unmanageable and to increase prison system safety and order.
The study findings were first covered in the Tampa Bay Times, but was syndicated by msn.com.
Cochran, an associate professor in UC’s School of Criminal Justice, is currently studying ESM in the Ohio prison system.
Featured photo at top of prision cell provided by Unsplash/Ayrus Hill.
Impact Lives Here
The University of Cincinnati is leading public urban universities into a new era of innovation and impact. Our faculty, staff and students are saving lives, changing outcomes and bending the future in our city's direction. Next Lives Here.
Related Stories
UC biologist talks about 'pearmageddon'
March 16, 2026
WLWT talks to UC biologist and Department Head Theresa Culley about invasive, nonnative Callery pear trees that are spreading across Ohio forests after they were introduced by landscapers more than 50 years ago.
Local media highlight completion of Blood Cancer Healing Center fourth and fifth floors
March 16, 2026
Local media including WLWT and the Cincinnati Business Courier highlighted the opening of research laboratories and the UC Osher Wellness Suite and Learning Kitchen at the University of Cincinnati Cancer Center’s Blood Cancer Healing Center.
Trial results support weekly buprenorphine treatment of opioid use disorder during pregnancy
March 16, 2026
Supported by the National Institutes of Health (NIH), researchers led by the University of Cincinnati's John Winhusen published clinical trial results in JAMA Internal Medicine that found administering weekly injectable extended-release buprenorphine for treatment of opioid use disorder during pregnancy led to higher rates of abstinence from illicit opioids than buprenorphine given daily under the tongue, one of the standard methods of treatment.